Header cover image
  • Investing Ideas
  • Brazilian Pharmaceuticals & Biotech Undervalued based on future growth

Brazilian Pharmaceuticals & Biotech Undervalued based on future growth

Results

2

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

2 companies

Hypera

Market Cap: R$15.1b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$21.46

7D

-0.9%

1Y

-11.4%

Blau Farmacêutica

Market Cap: R$2.1b

A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

BLAU3

R$8.90

7D

3.2%

1Y

-6.4%